BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18958356)

  • 1. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
    Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
    Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of VEGF in prostate cancer and its correlation with ET-1].
    Zhou WQ; Yin HL; Zhang ZY; Yi XM; Ge JP; Zhou SG; Cheng W; Wei W; Ma HQ; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2008 Nov; 14(11):987-92. PubMed ID: 19102498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
    Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
    Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
    Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
    Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
    Zhen B; Shen Y; Zhang YM; Zhu CH; Liu ZL
    Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vinculin and the androgen receptor in prostate cancer: expressions and correlations].
    Zhu LY; Zhong KB; Lu SX; He LY
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):794-8. PubMed ID: 21171262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features.
    Aslan G; Irer B; Tuna B; Yorukoglu K; Saatcioglu F; Celebi I
    Pathol Res Pract; 2006; 202(2):93-8. PubMed ID: 16413692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
    Lai JS; Xia Q; Zhang XB; Zhao GP; Xu SL; Zheng DS
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [P53 expression and its clinical significance in prostatic carcinoma].
    Jiang T; Jiang H; Song XS; Li XC; Li QL
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):448-51, 454. PubMed ID: 15999492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].
    Yu T; Zhu SX; Zheng S; Chen SP
    Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of sexual hormon receptors in prostatic cancer tissues].
    Ding T; Che WJ; Chen TJ
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):50-2, 56. PubMed ID: 16483160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
    Xu C; Zhou T; He M; Sun Y
    Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.